Siponimod
Back to searchMolecule Structure
Scientific Name
Siponimod
Description of the Drug
Siponimod is a medication used to treat relapsing multiple sclerosis.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB12371
http://www.drugbank.ca/drugs/DB12371
Brand Name(s)
Not Available
Company Owner(s)
Novartis Pharmaceuticals Corp
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Sphingosine 1-phosphate receptor Edg-1 | SINGLE PROTEIN | AGONIST | CHEMBL4333 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL641699 | |
| DrugBank | DB12371 | |
| PubChem: Thomson Pharma | 87331718 | |
| PubChem | 44599207 | |
| PDBe | J8C | |
| BindingDB | 50428142 | |
| EPA CompTox Dashboard | DTXSID40153847 | |
| DrugCentral | 5326 | |
| ChemicalBook | CB62725945 | |
| Guide to Pharmacology | 9289 | |
| rxnorm | SIPONIMOD | MAYZENT |
| ZINC | ZINC000006717453 |
